ArticleOncoTargets and therapy2019

Tanshinone IIA Reverses Oxaliplatin Resistance In Human Colorectal Cancer Via Inhibition Of ERK/Akt Signaling Pathway.

Yonggang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.